CD73⁺ extracellular vesicles inhibit angiogenesis through adenosine A_2B receptor signalling

References

• Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003;9(6):653–20.
   PubMed Web of Science ®Google Scholar
• Bikfalvi A. History and conceptual developments in vascular biology and angiogenesis research: a personal view. Angiogenesis. 2017;20:463–478.
   Web of Science ®Google Scholar
• Carmeliet P, Jain RK. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov. 2011;10:417–427.
   PubMed Web of Science ®Google Scholar
• Usui Y, Westenskow PD, Murinello S, et al. Angiogenesis and eye disease. Annu Rev Vis Sci. 2015;1:155–184.
   Web of Science ®Google Scholar
• Cabral T, Mello LGM, Lima LH, et al. Retinal and choroidal angiogenesis: a review of new targets. Int J Retina Vitreous. 2017;3:31.
   Google Scholar
• Sagar SM, Yance D, Wong RK. Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1. Curr Oncol Tor Ont. 2006;13:14–26.
   PubMedGoogle Scholar
• Pollina EA, Legesse-Miller A, Haley E, et al. Regulating the angiogenic balance in tissues: a potential role for the proliferative state of fibroblasts. Cell Cycle Georget Tex. 2008;7:2056–2070.
   PubMed Web of Science ®Google Scholar
• Newman AC, Nakatsu MN, Chou W, et al. The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation. Mol Biol Cell. 2011;22:3791–3800.
   PubMed Web of Science ®Google Scholar
• Rohani MG, Parks WC. Matrix remodeling by MMPs during wound repair. Matrix Biol. 2015;44–46:113–121.
   PubMed Web of Science ®Google Scholar
• Li B, Wang JH-C. Fibroblasts and myofibroblasts in wound healing: force generation and measurement. J Tissue Viability. 2011;20(4):108–120.
   PubMed Web of Science ®Google Scholar
• Iyer VR, Eisen MB, Ross DT, et al. The transcriptional program in the response of human fibroblasts to serum. Science. 1999;283(5398):83–87.
   Google Scholar
• Darvishi B, Majidzadeh-A K, Ghadirian R, et al. Recruited bone marrow derived cells, local stromal cells and IL-17 at the front line of resistance development to anti-VEGF targeted therapies. Life Sci. 2019;217:34–40.
   Web of Science ®Google Scholar
• Armulik A, Genové G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell. 2011;21:193–215.
   PubMed Web of Science ®Google Scholar
• Chang WG, Andrejecsk JW, Kluger MS, et al. Pericytes modulate endothelial sprouting. Cardiovasc Res. 2013;100:492–500.
   PubMed Web of Science ®Google Scholar
• Durham JT, Surks HK, Dulmovits BM, et al. Pericyte contractility controls endothelial cell cycle progression and sprouting: insights into angiogenic switch mechanics. Am J Physiol Cell Physiol. 2014;307:C878–892.
   Web of Science ®Google Scholar
• Simonavicius N, Ashenden M, van Weverwijk A, et al. Pericytes promote selective vessel regression to regulate vascular patterning. Blood. 2012;120(7):1516–1527.
   Web of Science ®Google Scholar
• Castro-Malaspina H, Gay RE, Resnick G, et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood. 1980;56(2):289–301.
   PubMed Web of Science ®Google Scholar
• Méndez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 2010;466(7308):829–834.
   PubMed Web of Science ®Google Scholar
• Ono N, Ono W, Mizoguchi T, et al. Vasculature-associated cells expressing nestin in developing bones encompass early cells in the osteoblast and endothelial lineage. Dev Cell. 2014;29:330–339.
   Web of Science ®Google Scholar
• Watt SM, Gullo F, van der Garde M, et al. The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential. Br Med Bull. 2013;108(1):25–53.
   Google Scholar
• Lin R-Z, Moreno-Luna R, Zhou B, et al. Equal modulation of endothelial cell function by four distinct tissue-specific mesenchymal stem cells. Angiogenesis. 2012;15:443–455.
   PubMed Web of Science ®Google Scholar
• Smadja DM, d’Audigier C, Guerin CL, et al. Angiogenic potential of BM MSCs derived from patients with critical leg ischemia. Bone Marrow Transplant. 2012;47:997–1000.
   Web of Science ®Google Scholar
• Chen J, Zhang ZG, Li Y, et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res. 2003;92:692–699.
   PubMed Web of Science ®Google Scholar
• Miyahara Y, Nagaya N, Kataoka M, et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med. 2006;12:459–465.
   PubMed Web of Science ®Google Scholar
• Ransohoff JD, Wu JC. Imaging stem cell therapy for the treatment of peripheral arterial disease. Curr Vasc Pharmacol. 2012;10(3):361–373. Available from: http://www.eurekaselect.com/96299/article
   Google Scholar
• Tao H, Han Z, Han ZC, et al. Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications. Stem Cells Int. 2016;2016:1314709. Available from: https://www.hindawi.com/journals/sci/2016/1314709/
   Google Scholar
• Kwon HM, Hur S-M, Park K-Y, et al. Multiple paracrine factors secreted by mesenchymal stem cells contribute to angiogenesis. Vascul Pharmacol. 2014;63:19–28.
   PubMed Web of Science ®Google Scholar
• Todorova D, Simoncini S, Lacroix R, et al. Extracellular vesicles in angiogenesis. Circ Res. 2017;120:1658–1673.
   PubMed Web of Science ®Google Scholar
• van der Pol E, Böing AN, Harrison P, et al. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev. 2012;64:676–705.
   PubMed Web of Science ®Google Scholar
• Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200:373–383.
   PubMed Web of Science ®Google Scholar
• Teng X, Chen L, Chen W, et al. Mesenchymal Stem Cell-Derived Exosomes Improve the Microenvironment of Infarcted Myocardium Contributing to Angiogenesis and Anti-Inflammation. Cell Physiol Biochem. 2015;37(6):2415–2424.
   Google Scholar
• Doeppner TR, Herz J, Görgens A, et al. Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl Med. 2015;4:1131–1143.
   PubMed Web of Science ®Google Scholar
• Anderson JD, Johansson HJ, Graham CS, et al. Comprehensive proteomic analysis of mesenchymal stem cell exosomes reveals modulation of angiogenesis via nuclear factor-KappaB signaling. Stem Cells Dayt Ohio. 2016;34:601–613.
   PubMed Web of Science ®Google Scholar
• Sahoo S, Klychko E, Thorne T, et al. Exosomes from human CD34+ stem cells mediate their pro-angiogenic paracrine activity. Circ Res. 2011;109:724–728.
   Web of Science ®Google Scholar
• Liang X, Zhang L, Wang S, et al. Exosomes secreted by mesenchymal stem cells promote endothelial cell angiogenesis by transferring miR-125a. J Cell Sci. 2016;129:2182–2189.
   PubMed Web of Science ®Google Scholar
• Ferguson SW, Wang J, Lee CJ, et al. The microRNA regulatory landscape of MSC-derived exosomes: a systems view. Sci Rep. 2018;8(1):1419.
   Google Scholar
• Marfy‐Smith SJ, Clarkin CE. Are mesenchymal stem cells so bloody great after all? Stem Cells Transl Med. 2017;6:3–6.
   Web of Science ®Google Scholar
• Otsu K, Das S, Houser SD, et al. Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells. Blood. 2009;113(18):4197–4205.
   PubMed Web of Science ®Google Scholar
• Menge T, Gerber M, Wataha K, et al. Human mesenchymal stem cells inhibit endothelial proliferation and angiogenesis via cell–cell contact through modulation of the VE-Cadherin/β-catenin signaling pathway. Stem Cells Dev. 2013;22(1):148–157.
   PubMed Web of Science ®Google Scholar
• Maffioli E, Nonnis S, Angioni R, et al. Proteomic analysis of the secretome of human bone marrow-derived mesenchymal stem cells primed by pro-inflammatory cytokines. J Proteomics. 2017;166:115–126.
   PubMed Web of Science ®Google Scholar
• Zanotti L, Sarukhan A, Dander E, et al. Encapsulated mesenchymal stem cells for in vivo immunomodulation. Leukemia. 2013;27(2):500–503.
   Web of Science ®Google Scholar
• Zanotti L, Angioni R, Calì B, et al. Mouse mesenchymal stem cells inhibit high endothelial cell activation and lymphocyte homing to lymph nodes by releasing TIMP-1. Leukemia. 2016;30(5):1143–1154.
   Web of Science ®Google Scholar
• Théry C, Amigorena S, Raposo G, et al. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006; Chapter 3. https://www.ncbi.nlm.nih.gov/pubmed/18228490
   Google Scholar
• Casey AE, Laster WR, Ross GL. Sustained enhanced growth of carcinoma EO771 in C57 black mice. Proc Soc Exp Biol Med Soc Exp Biol Med N Y N. 1951;77:358–362.
   PubMed Web of Science ®Google Scholar
• Herkenne S, Paques C, Nivelles O, et al. The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis [published correction appears in Sci Signal. 2015 Dec 8;8(406):er9]. Sci Signal. 2015;8(403):ra117.
   Google Scholar
• Filippi A, Dal Sasso E, Iop L, et al. Multimodal label-free ex vivo imaging using a dual-wavelength microscope with axial chromatic aberration compensation. J Biomed. Opt. 2018;23:1–9.
   Web of Science ®Google Scholar
• Kaundal U, Bagai U, Rakha A. Immunomodulatory plasticity of mesenchymal stem cells: a potential key to successful solid organ transplantation. J Transl Med. 2018;16(1):31.
   Google Scholar
• Rupert DLM, Claudio V, Lässer C, et al. Methods for the physical characterization and quantification of extracellular vesicles in biological samples. Biochim Biophys Acta BBA - Gen Subj. 2017;1861:3164–3179.
   PubMed Web of Science ®Google Scholar
• Kowal J, Arras G, Colombo M, et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci USA. 2016;113:E968–977.
   PubMed Web of Science ®Google Scholar
• Liang -C-C, Park AY, Guan J-L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007;2:329–333.
   PubMed Web of Science ®Google Scholar
• Bhattacharya R, Kwon J, Li X, et al. Distinct role of PLCbeta3 in VEGF-mediated directional migration and vascular sprouting. J Cell Sci. 2009;122:1025–1034.
   Web of Science ®Google Scholar
• Brem H, Kodra A, Golinko MS, et al. Mechanism of sustained release of vascular endothelial growth factor in accelerating experimental diabetic healing. J Invest Dermatol. 2009;129:2275–2287.
   PubMed Web of Science ®Google Scholar
• Guo D, Wang Q, Li C, et al. VEGF stimulated the angiogenesis by promoting the mitochondrial functions.. Oncotarget. 2017;8(44):77020–77027.
   Google Scholar
• Guo S, Lok J, Liu Y, et al. Assays to examine endothelial cell migration, tube formation, and gene expression profiles. Methods Mol Biol. 2014;1135:393–402.
   Google Scholar
• Stahl A, Connor KM, Sapieha P, et al. The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci. 2010;51:2813–2826.
   PubMed Web of Science ®Google Scholar
• Aaberg-Jessen C, Sørensen MD, Matos ALSA, et al. Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas. BMC Cancer. 2018;18(1):270.
   Google Scholar
• Jung -K-K, Liu X-W, Chirco R, et al. Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein. EMBO J. 2006;25(17):3934–3942.
   PubMed Web of Science ®Google Scholar
• Hurd TR, DeGennaro M, Lehmann R. Redox regulation of cell migration and adhesion. Trends Cell Biol. 2012;22(2):107–115.
   Web of Science ®Google Scholar
• Abid MR, Kachra Z, Spokes KC, et al. NADPH oxidase activity is required for endothelial cell proliferation and migration. FEBS Lett. 2000;486:252–256.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zang QS, Liu Z, et al. Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen species. Am J Physiol - Cell Physiol. 2011;301:C695–C704.
   Web of Science ®Google Scholar
• Moldovan L, Mythreye K, Goldschmidt-Clermont PJ, et al. Reactive oxygen species in vascular endothelial cell motility. Roles of NAD(P)H oxidase and Rac1. Cardiovasc Res. 2006;71:236–246.
   PubMed Web of Science ®Google Scholar
• Kim Y-W, Byzova TV. Oxidative stress in angiogenesis and vascular disease. Blood. 2014;123:625–631.
   PubMed Web of Science ®Google Scholar
• Rezabakhsh A, Ahmadi M, Khaksar M, et al. Rapamycin inhibits oxidative/nitrosative stress and enhances angiogenesis in high glucose-treated human umbilical vein endothelial cells: Role of autophagy. Biomed Pharmacother. 2017;93:885–894.
   Google Scholar
• Urbich C, Dernbach E, Aicher A, et al. CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation. 2002;106:981–986.
   PubMed Web of Science ®Google Scholar
• Jiang C, Jiang L, Li Q, et al. Acrolein induces NLRP3 inflammasome-mediated pyroptosis and suppresses migration via ROS-dependent autophagy in vascular endothelial cells. Toxicology. 2018;410:26–40.
   PubMed Web of Science ®Google Scholar
• Davalli P, Mitic T, Caporali A, et al. ROS, cell senescence, and novel molecular mechanisms in aging and age-related diseases. Oxid Med Cell Longev. 2016;2016:3565127.
   PubMed Web of Science ®Google Scholar
• Fan LM, Geng L, Cahill-Smith S, et al. Nox2 contributes to age-related oxidative damage to neurons and the cerebral vasculature. J Clin Invest. 2019;129(8):3374–3386.
   Google Scholar
• Du J, Fan LM, Mai A, et al. Crucial roles of Nox2-derived oxidative stress in deteriorating the function of insulin receptors and endothelium in dietary obesity of middle-aged mice: dietary obesity and vascular oxidative stress. Br J Pharmacol. 2013;170:1064–1077.
   PubMed Web of Science ®Google Scholar
• Förstermann U, Xia N, Li H. Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ Res. 2017;120:713–735.
   PubMed Web of Science ®Google Scholar
• Thakur S, Du J, Hourani S, et al. Inactivation of adenosine A2A receptor attenuates basal and angiotensin II-induced ROS production by Nox2 in endothelial cells. J Biol Chem. 2010;285:40104–40113.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Rajamani U, Labazi H, et al. Involvement of NADPH oxidase in A2A adenosine receptor-mediated increase in coronary flow in isolated mouse hearts. Purinergic Signal. 2015;11(2):263–273.
   Google Scholar
• Cauwels A, Rogge E, Vandendriessche B, et al. Extracellular ATP drives systemic inflammation, tissue damage and mortality. Cell Death Dis. 2014;5:e1102.
   Web of Science ®Google Scholar
• Ghiringhelli F, Bruchard M, Chalmin F, et al. Production of adenosine by ectonucleotidases: A key factor in tumor immunoescape. J Biomed Biotechnol. 2012;2012:473712. Available from: https://www.hindawi.com/journals/bmri/2012/473712/
   Google Scholar
• Smyth LA, Ratnasothy K, Tsang JY, et al. CD73 expression on extracellular vesicles derived from CD4+ CD25+ Foxp3+ T cells contributes to their regulatory function. Eur J Immunol. 2013;43(9):2430–2440.
   Google Scholar
• Whiteside TL. Exosomes and tumor-mediated immune suppression. J Clin Invest. 2016;126:1216–1223.
   PubMed Web of Science ®Google Scholar
• Sands WA, Palmer TM. Adenosine receptors and the control of endothelial cell function in inflammatory disease. Immunol Lett. 2005;101:1–11.
   PubMed Web of Science ®Google Scholar
• Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell. 2011;146:873–887.
   PubMed Web of Science ®Google Scholar
• Nishimura S, Manabe I, Nagasaki M, et al. Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes. 2007;56:1517–1526.
   PubMed Web of Science ®Google Scholar
• MacDonald IJ, Liu SC, Su CM, et al. Implications of Angiogenesis Involvement in Arthritis. Int J Mol Sci. 2018;19(7):2012.
   Google Scholar
• Yu QC, Song W, Wang D, et al. Identification of blood vascular endothelial stem cells by the expression of protein C receptor. Cell Res. 2016;26:1079–1098.
   PubMed Web of Science ®Google Scholar
• Zhang M, Rehman J, Malik AB. Endothelial progenitor cells and vascular repair. Curr Opin Hematol. 2014;21:224–228.
   PubMed Web of Science ®Google Scholar
• Stapor PC, Sweat RS, Dashti DC, et al. Pericyte dynamics during angiogenesis: new insights from new identities. J Vasc Res. 2014;51:163–174.
   PubMed Web of Science ®Google Scholar
• Xing F, Saidou J, Watabe K. Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci (Landmark Ed). 2010;15:166–179.
   Google Scholar
• Lyons TR, O'Brien J, Borges VF, et al. Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med. 2011;17(9):1109–1115.
   Google Scholar
• Santos AM, Jung J, Aziz N, et al. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. J Clin Invest. 2009;119:3613–3625.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick JR, Frederick JR, McCormick RC, et al. Tissue-engineered pro-angiogenic fibroblast scaffold improves myocardial perfusion and function and limits ventricular remodeling after infarction. J Thorac Cardiovasc Surg. 2010;140:667–676.
   Web of Science ®Google Scholar
• Yong KW, Choi JR, Mohammadi M, et al. Mesenchymal Stem Cell Therapy for Ischemic Tissues. Stem Cells Int. 2018;2018:8179075. Available from: https://www.hindawi.com/journals/sci/2018/8179075/
   Google Scholar
• Doorn J, Moll G, Le Blanc K, et al. Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements. Tissue Eng Part B Rev. 2012;18:101–115.
   PubMed Web of Science ®Google Scholar
• Fierabracci A, Del Fattore A, Luciano R, et al. Recent advances in mesenchymal stem cell immunomodulation: the role of microvesicles. Cell Transplant. 2015;24:133–149.
   Web of Science ®Google Scholar
• Coumans FAW, Brisson AR, Buzas EI, et al. Methodological guidelines to study extracellular vesicles. Circ Res. 2017;120:1632–1648.
   PubMed Web of Science ®Google Scholar
• Rani S, Ryan AE, Griffin MD, et al. Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications. Mol Ther. 2015;23:812–823.
   PubMed Web of Science ®Google Scholar
• Gong M, Yu B, Wang J, et al. Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesis. Oncotarget. 2017;8:45200–45212.
   PubMedGoogle Scholar
• Chen J, Liu Z, Hong MM, et al. Proangiogenic compositions of microvesicles derived from human umbilical cord mesenchymal stem cells. PLoS One. 2014;9:e115316.
   PubMed Web of Science ®Google Scholar
• Gonzalez-King H, García NA, Ontoria-Oviedo I, et al. Hypoxia Inducible Factor-1α Potentiates Jagged 1-mediated angiogenesis by mesenchymal stem cell-derived exosomes. Stem Cells. 2017;35(7):1747–1759.
   Google Scholar
• Liu J, Hao H, Xia L, et al. Hypoxia pretreatment of bone marrow mesenchymal stem cells facilitates angiogenesis by improving the function of endothelial cells in diabetic rats with lower ischemia. PLoS One. 2015;10(5):e0126715.
   Google Scholar
• Xue C, Shen Y, Li X, et al. Exosomes derived from hypoxia-treated human adipose mesenchymal stem cells enhance angiogenesis through the PKA signaling pathway. Stem Cells Dev. 2018;27:456–465.
   PubMed Web of Science ®Google Scholar
• Zou X, Gu D, Xing X, et al. Human mesenchymal stromal cell-derived extracellular vesicles alleviate renal ischemic reperfusion injury and enhance angiogenesis in rats. Am J Transl Res. 2016;8:4289–4299.
   Web of Science ®Google Scholar
• Zou X, Yu Y, Lin S, et al. Comprehensive miRNA analysis of human umbilical cord-derived mesenchymal stromal cells and extracellular vesicles. Kidney Blood Press Res. 2018;43:152–161.
   Web of Science ®Google Scholar
• Ren W, Hou J, Yang C, et al. Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery. J Exp Clin Cancer Res. 2019;38(1):62.
   Google Scholar
• Haskó G, Linden J, Cronstein B, et al. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov. 2008;7(9):759–770.
   PubMed Web of Science ®Google Scholar
• Bono MR, Fernández D, Flores-Santibáñez F, et al. CD73 and CD39 ectonucleotidases in T cell differentiation: beyond immunosuppression. FEBS Lett. 2015;589:3454–3460.
   PubMed Web of Science ®Google Scholar
• Antonioli L, Pacher P, Vizi ES, et al. CD39 and CD73 in immunity and inflammation. Trends Mol Med. 2013;19:355–367.
   PubMed Web of Science ®Google Scholar
• Bouma MG, van den Wildenberg FA, Buurman WA. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am J Physiol. 1996;270:C522–529.
   PubMedGoogle Scholar
• Bours MJL, Swennen ELR, Di Virgilio F, et al. Adenosine 5ʹ-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther. 2006;112:358–404.
   PubMed Web of Science ®Google Scholar
• Ushio-Fukai M, Nakamura Y. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett. 2008;266:37–52.
   PubMed Web of Science ®Google Scholar
• Łuczak K, Balcerczyk A, Soszyński M, et al. Low concentration of oxidant and nitric oxide donors stimulate proliferation of human endothelial cells in vitro. Cell Biol Int. 2004;28:483–486.
   PubMed Web of Science ®Google Scholar
• Ushio-Fukai M. Localizing NADPH oxidase-derived ROS. Sci STKE. 2006;2006(349):re8.
   Google Scholar
• Lum H, Roebuck KA. Oxidant stress and endothelial cell dysfunction. Am J Physiol - Cell Physiol. 2001;280:C719–C741.
   PubMed Web of Science ®Google Scholar
• Bhayadia R, Schmidt BM, Melk A, et al. Senescence-Induced Oxidative Stress Causes Endothelial Dysfunction. J Gerontol A Biol Sci Med Sci. 2016;71(2):161–169
   Google Scholar
• Kobayashi N, DeLano FA, Schmid-Schönbein GW. Oxidative stress promotes endothelial cell apoptosis and loss of microvessels in the spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol. 2005;25:2114–2121.
   PubMed Web of Science ®Google Scholar
• Dong LF, Swettenham E, Eliasson J, et al. Vitamin E analogues inhibit angiogenesis by selective induction of apoptosis in proliferating endothelial cells: the role of oxidative stress. Cancer Res. 2007;67(24):11906–11913.
   Google Scholar
• El-Awady MS, Ansari HR, Fil D, et al. NADPH oxidase pathway is involved in aortic contraction induced by A3 adenosine receptor in mice. J Pharmacol Exp Ther. 2011;338(2):711–717
   Google Scholar
• Luu NT, McGettrick HM, Buckley CD, et al. Crosstalk between mesenchymal stem cells and endothelial cells leads to downregulation of cytokine-induced leukocyte recruitment. Stem Cells. 2013;31(12):2690–2702.
   Google Scholar
• Jászai J, Schmidt MHH. Trends and challenges in tumor anti-angiogenic therapies. Cells. 2019;8:1102.
   PubMed Web of Science ®Google Scholar
• Keating GM. Bevacizumab: a review of its use in advanced cancer. Drugs. 2014;74:1891–1925.
   PubMed Web of Science ®Google Scholar
• Bergers G, Hanahan D. Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer. 2008;8:592–603.
   PubMed Web of Science ®Google Scholar
• Jain RK. Antiangiogenic therapy for cancer: current and emerging concepts. Oncology (Williston Park). 2005;19(4 Suppl 3):7–16.
   Google Scholar
• Saltz LB, Lenz HJ, Kindler HL, et al. Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study. J Clin Oncol. 2007;25(29):4557–4561.
   Google Scholar